Cargando…
Effects of GV1001 on Language Dysfunction in Patients With Moderate-to-Severe Alzheimer’s Disease: Post Hoc Analysis of Severe Impairment Battery Subscales
BACKGROUND AND PURPOSE: The efficacy and safety of GV1001 have been demonstrated in patients with moderate-to-severe Alzheimer’s disease (AD). In this study, we aimed to further demonstrate the effectiveness of GV1001 using subscales of the Severe Impairment Battery (SIB), which is a validated measu...
Autores principales: | Kwon, Hyuk Sung, Koh, Seong-Ho, Choi, Seong Hye, Jeong, Jee Hyang, Na, Hae Ri, Lee, Chan Nyoung, Yang, YoungSoon, Lee, Ae Young, Lee, Jae-Hong, Park, Kyung Won, Han, Hyun Jeong, Kim, Byeong C., Park, Jinse, Lee, Jee-Young, Lee, Kyu-Yong, Kim, Sangjae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Dementia Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400345/ https://www.ncbi.nlm.nih.gov/pubmed/37545861 http://dx.doi.org/10.12779/dnd.2023.22.3.100 |
Ejemplares similares
-
Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer’s disease already receiving donepezil: a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trial
por: Koh, Seong-Ho, et al.
Publicado: (2021) -
GV1001 Inhibits the Severity of the Ligature-Induced Periodontitis and the Vascular Lipid Deposition Associated with the Periodontitis in Mice
por: Kim, Sharon Y., et al.
Publicado: (2023) -
Neuroprotective Effects of GV1001 in Animal Stroke Model and Neural Cells Subject to Oxygen-Glucose Deprivation/Reperfusion Injury
por: Kwon, Hyuk Sung, et al.
Publicado: (2021) -
Novel Peptide Vaccine GV1001 Rescues Hearing in Kanamycin/Furosemide-Treated Mice
por: Kim, Shin Hye, et al.
Publicado: (2018) -
The anti-fibrotic effect of GV1001 combined with gemcitabine on treatment of pancreatic ductal adenocarcinoma
por: Park, Joo Kyung, et al.
Publicado: (2016)